Bio-Path Holdings (BPTH) Misses Q2 EPS by 9c
Bio-Path Holdings (NASDAQ: BPTH) reported Q2 EPS of ($0.53), $0.09 worse than the analyst estimate of ($0.44).
For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.
Bio-Path Holdings (NASDAQ: BPTH) reported Q2 EPS of ($0.53), $0.09 worse than the analyst estimate of ($0.44).
For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.